Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 3 studies | 21% ± 6% | |
dendritic cell | 3 studies | 24% ± 9% |
Insufficient scRNA-seq data for expression of ELF4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 2021.19 | 359 / 359 | 100% | 52.17 | 286 / 286 |
esophagus | 100% | 1449.59 | 1443 / 1445 | 100% | 65.05 | 183 / 183 |
intestine | 100% | 2230.29 | 966 / 966 | 100% | 47.55 | 526 / 527 |
ovary | 100% | 2466.18 | 180 / 180 | 100% | 55.08 | 428 / 430 |
bladder | 100% | 2338.81 | 21 / 21 | 99% | 51.15 | 499 / 504 |
lung | 100% | 3212.68 | 578 / 578 | 98% | 38.70 | 1134 / 1155 |
uterus | 100% | 2153.95 | 170 / 170 | 98% | 45.49 | 449 / 459 |
breast | 100% | 2026.30 | 459 / 459 | 97% | 25.72 | 1081 / 1118 |
kidney | 100% | 1113.82 | 89 / 89 | 94% | 23.06 | 850 / 901 |
thymus | 97% | 852.43 | 631 / 653 | 78% | 12.50 | 472 / 605 |
skin | 100% | 2270.75 | 1809 / 1809 | 74% | 14.70 | 347 / 472 |
adrenal gland | 97% | 713.47 | 251 / 258 | 62% | 11.46 | 143 / 230 |
prostate | 100% | 1293.63 | 245 / 245 | 35% | 3.95 | 178 / 502 |
pancreas | 33% | 182.84 | 107 / 328 | 98% | 35.70 | 174 / 178 |
adipose | 100% | 2492.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 50.60 | 29 / 29 |
spleen | 100% | 3621.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 50.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.32 | 1 / 1 |
peripheral blood | 100% | 5455.36 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1396.89 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 84% | 633.61 | 726 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 8.41 | 50 / 80 |
liver | 9% | 49.27 | 21 / 226 | 19% | 4.45 | 77 / 406 |
brain | 5% | 23.73 | 123 / 2642 | 23% | 3.16 | 164 / 705 |
muscle | 17% | 88.17 | 134 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0001866 | Biological process | NK T cell proliferation |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0001787 | Biological process | natural killer cell proliferation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0016605 | Cellular component | PML body |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ELF4 |
Protein name | E74 like ETS transcription factor 4 ETS-related transcription factor Elf-4 (E74-like factor 4) (Myeloid Elf-1-like factor) |
Synonyms | ELFR MEF |
Description | FUNCTION: Transcriptional activator that binds to DNA sequences containing the consensus 5'-WGGA-3'. Transactivates promoters of the hematopoietic growth factor genes CSF2, IL3, IL8, and of the bovine lysozyme gene. Acts synergistically with RUNX1 to transactivate the IL3 promoter (By similarity). Transactivates the PRF1 promoter in natural killer (NK) cells and CD8+ T cells . Plays a role in the development and function of NK and NK T-cells and in innate immunity. Controls the proliferation and homing of CD8+ T-cells via the Kruppel-like factors KLF4 and KLF2 (By similarity). Controls cell senescence in a p53-dependent manner. Can also promote cellular transformation through inhibition of the p16 pathway. Is a transcriptional regulator of inflammation, controlling T-helper 17 (Th17) cells and macrophage inflammatory responses. Required for sustained transcription of anti-inflammatory genes, including IL1RN . Is a negative regulator of pro-inflammatory cytokines expression including IL17A, IL1B, IL6, TNFA and CXCL1 . Down-regulates expression of TREM1, a cell surface receptor involved in the amplification of inflammatory responses (By similarity) . . |
Accessions | Q99607 B1AL80 ENST00000335997.11 ENST00000434609.1 ENST00000308167.10 |